Smith and Nephew22 Jan 2019 16:34
RNS - Smith & Nephew plc (LSE:SN, NYSE:SNN), the global medical technology business, announces it has completed the acquisition of Ceterix® Orthopaedics, Inc, the developer of the NovoStitch® Pro Meniscal Repair System. The acquisition supports the Company's strategy to invest in innovative technologies that meet unmet clinical needs.
At a cost of $50m that must put us firmly on the radar for a future T/O.
Starting to wonder if that's the only way we'll get this ridiculously low SP higher.